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Genetic Predisposition to Neonatal Disseminated Herpes Simplex Virus
Infection
L Cummings1, A Holmes1, M Gibson2, J Johnston2, Emily Farrow2, and V Sampath1
1Division of Neonatology, Pediatrics, Children’s Mercy Hospital, Kansas City, MO
2The Genomic Medicine Center at CMH, Kansas City, MO
Background: Neonatal disseminated herpes simplex virus (HSV) infection is a
devastating disease with mortality rates as high as 80-90%, if left untreated. Despite
advances in early diagnosis with risk-based screening, mortality rates have
increased. Although case reports have identified genetic variants in Toll-like
receptor 3 (TLR3) in patients with HSV encephalitis (HSE), whether variants in the
TLR or similar pathways regulate susceptibility to disseminated disease remains
unknown.
Objective: Our primary aim is to determine whether pathogenic variants in 7 genes
associated with the TLR3 axis are present in infants with disseminated HSV. Our
secondary aim is to discover whether variants in a broader range of genes linked to
the immune response to viral infection are associated with any HSV phenotype.
Design/Methods: Hypothesis-generating study investigating the possibility of
genetic predisposition for disseminated HSV. Blood samples, from infants diagnosed
with HSV prior to 28 days of life, are collected for DNA extraction. Whole exome
sequencing is performed using bar coded, high throughput sequencing (MiSeq,
Illumina Inc.). Variants will be annotated by custom software (RUNES) based on
predicted pathogenicity. Variants identified in our candidate genes (TLR3,
UNC93B1, TICAM1, TRAF3, TBK1, and IRF3) and immunodeficiency genes will be
annotated as per the American College of Medical Genetics and Genomics (ACMG)
pathogenicity category (1-3). Variants with minor allele frequency (MAF) values <
1% will be included in the results.
Results: Seven infants with HSV have been genotyped: 5 disseminated and 2
Skin/Eye/Mouth (SEM) disease. There are 5 males and 2 females included, ranging
from 30–40 weeks gestational age. Sequencing data from our primary analysis
revealed that Infant 1 has 3 variants of interest (Table 1). Two variants were
identified in the TBK1 gene (ACMG 1,2) and 1 variant in the IRF3 gene (ACMG 2).
Variants in both genes have been associated with HSE. Our secondary analysis
identified 7 potentially deleterious variants in genes associated with the immune
response to virus infection, from viral recognition to induction of IFN production
(Table 2).
Conclusion: Our preliminary data from the primary analysis suggests the TBK1 and
IRF3 genes may play a role in the development of disseminated HSV, as well as HSE.
Our secondary analysis suggests the presence of novel variants in genes associated
with pathways related to the immune response to viruses. These may increase the
susceptibility to disseminated neonatal HSV disease.

